AXSM - 3 Surefire Stocks to End 2022 on a Good Note
This year hasn't been the easiest for investors. The three major indexes headed into bear territory. Many of even the strongest stocks suffered. And as a result, investors' portfolios suffered, too. But there's reason to be positive as we exit this year and enter a new one.
First of all, bear markets don't last forever. We don't know the timing of the next bull market -- but we know it will eventually come. Meanwhile, to end 2022 on a positive note, it's a good idea to invest in stocks that are on the rise -- or ones that are ripe for a rebound. Here are three that could add a positive spark to your portfolio.
Axsome Therapeutics (NASDAQ: AXSM) has climbed a whopping 100% this year. But there's reason this supercharged biotech could gain more over time. Axsome launched its first two products this year. One -- sleep disorder drug Sunosi -- it acquired from Jazz Pharmaceuticals earlier this spring. The other, antidepressant Auvelity, it commercialized this fall.
For further details see:
3 Surefire Stocks to End 2022 on a Good Note